The year 2018 was a watershed year of downs for the Indian Journal of Medical and Paediatric Oncology (IJMPO), but 2019 beckons the arising of the “Phoenix” from its ashes.
A new-look journal with a new philosophy along with a new set of editorial board members
and reviewers. The journal, an official publication of the Indian Society of Medical
and Paediatric Oncology, is directed to caring of cancer patients with or at risk
of cancer, which is to advance excellence in oncology treatment and quality of cancer
care.
The aim of this journal as set forth by the new editor-in-chief and his team is evidence-based
content for oncology care providers. The decision is to have clear, concise, comprehensive,
and well-referenced articles.
All manuscripts that have been or will be submitted to IJMPO must only be under the
consideration of the Journal. The articles must be original and nonplagiarised. All
the submitted articles are subjected to plagiarism check and peer review, and the
articles will be judged on the quality of work and suitability for IJMPO audience.
The editors support the principles of financial disclosures and are taking steps to
ensure that all stakeholders understand and comply with its policy. The journal is
also looking forward to a robust privacy policy. Already submitted and accepted articles previously will also be subjected to the same
rigor.
The dynamics of the editorial board and the vibrancy of the young editorial board
in whom the society has placed its trust will take the Journal to the next echelon
and we enter the world of “Write in India; Publish in India; Index Globally.”
I look forward to a literacy feast in scientific medical writing.
